Skip to main content
Clinical Trials/NCT05458817
NCT05458817UnknownNot Applicable

Digital-technology Based Interventions on Treatment of Migraine.

Tartu University Hospital1 site in 1 country600 target enrollmentStarted: January 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
600
Locations
1
Primary Endpoint
headache frequency

Study Overview

Brief Summary

The main aim of the research: To develop an interdisciplinary treatment platform based on digital technology and test the operation and effectiveness of digital interventions in comparison with conventional multidisciplinary treatment or treatment standards (incl. Paper diary, nurse counseling, physiotherapy, cognitive-behavioral therapy).

Detailed Description

Aims and purpose:

The main aim of the research: To develop an interdisciplinary treatment platform based on digital technology and test the operation and effectiveness of digital interventions in comparison with conventional multidisciplinary treatment or treatment standards (incl. Paper diary, nurse counseling, physiotherapy, cognitive-behavioral therapy).

Sub-aims:

To evaluate the effectiveness of interventions based on digital technology and their impact on the quality of life, comparing them with the interventions or treatment standards performed by ordinary specialists.

Assess the applicability and accessibility of digital technology-based interventions in the healthcare system against a treatment standard.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 64 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •diagnosed migraine, frequent episodic, headache days a month 8-14 days;
  • •patient age 18-64 years;
  • •very good command of the Estonian language both orally and in writing.

Exclusion Criteria

  • •headaches lasting less than 8 days and more than 14 days per month;
  • •all other primary and/or secondary diagnoses of headache;
  • •under the age of 18 or over 64;
  • •currently severe depression;
  • •psychotic disorders;
  • •pregnancy and lactation;
  • •severe somatic disease;
  • •severe organic mental disorders;
  • •other chronic pain;
  • •addictive disorders.

Arms & Interventions

1. Digital diary

Experimental

75 participants in the group

Intervention: digital platform (Other)

2. Paper diary

Active Comparator

75 participants in the group

Intervention: digital platform (Other)

3. Digital: diary and headache nurse

Experimental

75 participants in the group

Intervention: digital platform (Other)

4. Paper diary and conventional headache nurse

Active Comparator

75 participants in the group

Intervention: digital platform (Other)

5. Digital: diary, headache nurse and clinal psychologist

Experimental

75 participants in the group

Intervention: digital platform (Other)

6. Paper diary, conventional headache nurse and conventional clinical psychologist

Active Comparator

75 participants in the group

Intervention: digital platform (Other)

7. Digital: diary, headache nurse, clinal psychologist and physiotherapist

Experimental

75 participants in the group

Intervention: digital platform (Other)

8. Paper diary, conventional: headache nurse, clinal psychologist and physiotherapist

Active Comparator

75 participants in the group

Intervention: digital platform (Other)

Outcomes

Primary Outcomes

headache frequency

Time Frame: 9 months

headache diary: number of headache days per month

headache frequency

Time Frame: 3 months

headache diary: number of headache days per month

headache frequency

Time Frame: 6 months

headache diary: number of headache days per month

Secondary Outcomes

  • Cost-effectiveness 2(9 months)
  • Pain acceptance Pain acceptance Pain acceptance(9 months)
  • Patient's willingness to pay for headache treatment(9 months)
  • medication use(9 months)
  • Patient satisfaction with treatment 1(3 months)
  • Pain-related anxiety(9 months)
  • Patient satisfaction with treatment 2(3 months)
  • Patient satisfaction with treatment 3(6 months)
  • Patient satisfaction with treatment 4(6 months)
  • Patient satisfaction with treatment 5(9 months)
  • The effect of headaches on everyday life(9 months)
  • Health related quality of life(9 months)
  • Cost-effectiveness 1(9 months)
  • Patient satisfaction with treatment 6(9 months)
  • medication use(3 months)
  • medication use(6 months)
  • The effect of headaches on everyday life(3 months)
  • The effect of headaches on everyday life(6 months)
  • Pain acceptance Pain acceptance Pain acceptance(3 months)
  • Pain acceptance Pain acceptance Pain acceptance(6 months)
  • Pain-related anxiety(3 months)
  • Pain-related anxiety(6 months)
  • Health related quality of life(3 months)
  • Health related quality of life(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials